393 related articles for article (PubMed ID: 25064061)
1. Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives.
Veenvliet JV; Smidt MP
Cell Mol Life Sci; 2014 Dec; 71(24):4703-27. PubMed ID: 25064061
[TBL] [Abstract][Full Text] [Related]
2. Specificity of Pitx3-Dependent Gene Regulatory Networks in Subsets of Midbrain Dopamine Neurons.
Bifsha P; Balsalobre A; Drouin J
Mol Neurobiol; 2017 Sep; 54(7):4921-4935. PubMed ID: 27514757
[TBL] [Abstract][Full Text] [Related]
3. Acquisition of the Midbrain Dopaminergic Neuronal Identity.
Mesman S; Smidt MP
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629812
[TBL] [Abstract][Full Text] [Related]
4. Specification of dopaminergic subsets involves interplay of En1 and Pitx3.
Veenvliet JV; Dos Santos MT; Kouwenhoven WM; von Oerthel L; Lim JL; van der Linden AJ; Koerkamp MJ; Holstege FC; Smidt MP
Development; 2013 Aug; 140(16):3373-84. PubMed ID: 23863478
[TBL] [Abstract][Full Text] [Related]
5. Impaired motor coordination in Pitx3 overexpression mice.
Kim H; Quan X; Seong Y; Kim J
Biochem Biophys Res Commun; 2014 Apr; 446(4):1211-8. PubMed ID: 24680684
[TBL] [Abstract][Full Text] [Related]
6. Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons.
Steinkellner T; Zell V; Farino ZJ; Sonders MS; Villeneuve M; Freyberg RJ; Przedborski S; Lu W; Freyberg Z; Hnasko TS
J Clin Invest; 2018 Feb; 128(2):774-788. PubMed ID: 29337309
[TBL] [Abstract][Full Text] [Related]
7. Midbrain dopaminergic neurons: a review of the molecular circuitry that regulates their development.
Hegarty SV; Sullivan AM; O'Keeffe GW
Dev Biol; 2013 Jul; 379(2):123-38. PubMed ID: 23603197
[TBL] [Abstract][Full Text] [Related]
8. A WNT1-regulated developmental gene cascade prevents dopaminergic neurodegeneration in adult En1(+/-) mice.
Zhang J; Götz S; Vogt Weisenhorn DM; Simeone A; Wurst W; Prakash N
Neurobiol Dis; 2015 Oct; 82():32-45. PubMed ID: 26049140
[TBL] [Abstract][Full Text] [Related]
9. The Crucial Roles of Pitx3 in Midbrain Dopaminergic Neuron Development and Parkinson's Disease-Associated Neurodegeneration.
Wang X; Chen X; Liu G; Cai H; Le W
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239960
[TBL] [Abstract][Full Text] [Related]
10. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
Ahlers-Dannen KE; Spicer MM; Fisher RA
Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
[TBL] [Abstract][Full Text] [Related]
11. Differential contribution of Ih to the integration of excitatory synaptic inputs in substantia nigra pars compacta and ventral tegmental area dopaminergic neurons.
Masi A; Narducci R; Resta F; Carbone C; Kobayashi K; Mannaioni G
Eur J Neurosci; 2015 Nov; 42(9):2699-706. PubMed ID: 26354486
[TBL] [Abstract][Full Text] [Related]
12. Differential Somatic Ca2+ Channel Profile in Midbrain Dopaminergic Neurons.
Philippart F; Destreel G; Merino-Sepúlveda P; Henny P; Engel D; Seutin V
J Neurosci; 2016 Jul; 36(27):7234-45. PubMed ID: 27383597
[TBL] [Abstract][Full Text] [Related]
13. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
[TBL] [Abstract][Full Text] [Related]
14. Dickkopf 3 Promotes the Differentiation of a Rostrolateral Midbrain Dopaminergic Neuronal Subset In Vivo and from Pluripotent Stem Cells In Vitro in the Mouse.
Fukusumi Y; Meier F; Götz S; Matheus F; Irmler M; Beckervordersandforth R; Faus-Kessler T; Minina E; Rauser B; Zhang J; Arenas E; Andersson E; Niehrs C; Beckers J; Simeone A; Wurst W; Prakash N
J Neurosci; 2015 Sep; 35(39):13385-401. PubMed ID: 26424886
[TBL] [Abstract][Full Text] [Related]
15. Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.
Liu G; Sgobio C; Gu X; Sun L; Lin X; Yu J; Parisiadou L; Xie C; Sastry N; Ding J; Lohr KM; Miller GW; Mateo Y; Lovinger DM; Cai H
Hum Mol Genet; 2015 Sep; 24(18):5299-312. PubMed ID: 26123485
[TBL] [Abstract][Full Text] [Related]
16. Pluripotent stem cell derived dopaminergic subpopulations model the selective neuron degeneration in Parkinson's disease.
Oosterveen T; Garção P; Moles-Garcia E; Soleilhavoup C; Travaglio M; Sheraz S; Peltrini R; Patrick K; Labas V; Combes-Soia L; Marklund U; Hohenstein P; Panman L
Stem Cell Reports; 2021 Nov; 16(11):2718-2735. PubMed ID: 34678205
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of mitochondrial integrity in midbrain dopaminergic neurons governed by a conserved developmental transcription factor.
Miozzo F; Valencia-Alarcón EP; Stickley L; Majcin Dorcikova M; Petrelli F; Tas D; Loncle N; Nikonenko I; Bou Dib P; Nagoshi E
Nat Commun; 2022 Mar; 13(1):1426. PubMed ID: 35301315
[TBL] [Abstract][Full Text] [Related]
18. The transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress.
Luk KC; Rymar VV; van den Munckhof P; Nicolau S; Steriade C; Bifsha P; Drouin J; Sadikot AF
J Neurochem; 2013 Jun; 125(6):932-43. PubMed ID: 23331067
[TBL] [Abstract][Full Text] [Related]
19. LRRK2-G2019S mice display alterations in glutamatergic synaptic transmission in midbrain dopamine neurons.
Skiteva O; Yao N; Sitzia G; Chergui K
J Neurochem; 2022 Apr; 161(2):158-172. PubMed ID: 35152441
[TBL] [Abstract][Full Text] [Related]
20. Molecular heterogeneity in the substantia nigra: A roadmap for understanding PD motor pathophysiology.
Gaertner Z; Azcorra M; Dombeck DA; Awatramani R
Neurobiol Dis; 2022 Dec; 175():105925. PubMed ID: 36372290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
